Alvotech And Cipla Expand Biosimilars Deal For Australia And New Zealand
After Partnering On Multiple Biosimilars In South Africa And Emerging Markets
Cipla has expanded its partnership with Alvotech to cover the commercialization of four biosimilars in Australia and New Zealand, building on an existing alliance covering South Africa and emerging markets.
